HALF YEARLY RESULTS
AstraZeneca Pharma India Ltd.
BSE
Jun 19, 04:01
9422.95
-311.70 ( -3.20%)
Volume
4381
Prev. Close
9734.65
Open Price
9599.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 19, 03:59
9410.50
-324.00 ( -3.33%)
Volume
40260
Prev. Close
9734.50
Open Price
9680.50
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
9410.50 (55)
You can view the
Halfyearly Results
for the last 5 years.
|
ISIN No
|
INE203A01020
|
Market Cap. ( ₹ in Cr. )
|
23526.25
|
P/BV
|
34.63
|
Book Value ( ₹ )
|
271.74
|
|
BSE Code
|
506820
|
52 Week High/Low ( ₹ )
|
10691/6070
|
FV/ML
|
2/1
|
P/E(X)
|
203.27
|
|
NSE Code
|
ASTRAZENEQ
|
Book Closure
|
05/07/2024
|
EPS ( ₹ )
|
46.30
|
Div Yield (%)
|
0.34
|
(₹ in Crs.)
| Net Sales/Income from operations | 920.77 | 795.52 | 688.99 | 606.54 | 534.51 |
| Total Income From Operations | 920.77 | 795.52 | 688.99 | 606.54 | 534.51 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 164.13 | 123.00 | 71.14 | 57.88 | 48.72 |
| Purchase of Traded Goods | 516.62 | 492.20 | 256.51 | 242.79 | 177.96 |
| Increase/Decrease in Stocks | -174.11 | -158.83 | 34.19 | -67.96 | -36.58 |
| Employees Cost | 128.44 | 129.00 | 121.21 | 120.24 | 129.54 |
| Depreciation | 26.76 | 13.23 | 7.47 | 7.47 | 8.38 |
| Admin. And Selling Expenses | 44.76 | 0.00 | 0.00 | 0.00 | 0.00 |
| Provisions And Contingencies | -0.17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 77.74 | 119.54 | 141.49 | 133.58 | 118.43 |
| Total Expenses | 784.17 | 718.14 | 632.01 | 494.01 | 446.46 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 136.60 | 77.38 | 56.98 | 112.53 | 88.06 |
| Other Income | 24.13 | 16.50 | 18.32 | 16.48 | 15.19 |
| P/L Before Interest, Excpt. Items & Tax | 160.73 | 93.89 | 75.30 | 129.01 | 103.25 |
| Interest | 1.01 | 0.45 | 0.55 | 0.65 | 0.28 |
| P/L Before Exceptional Items & Tax | 159.72 | 93.43 | 74.75 | 128.36 | 102.97 |
| Exceptional Items | -39.23 | -57.56 | 0.00 | 16.43 | -40.23 |
| P/L Before Tax | 120.49 | 35.87 | 74.75 | 144.78 | 62.74 |
| Tax | 31.39 | 9.23 | 19.47 | 38.55 | 16.16 |
| P/L After Tax from Ordinary Activities | 89.10 | 26.64 | 55.28 | 106.23 | 46.58 |
| Net Profit/Loss For the Period | 89.10 | 26.64 | 55.28 | 106.23 | 46.58 |
| | | | | | |
| Equity Share Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserves And Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 583.69 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 35.64 | 10.65 | 22.11 | 42.49 | 18.63 |
| Diluted EPS (Rs.) | 35.64 | 10.65 | 22.11 | 42.49 | 18.63 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | 35.64 | 10.65 | 22.11 | 42.49 | 18.63 |
| Diluted EPS (Rs.) | 0.00 | 10.65 | 0.00 | 42.49 | 0.00 |
| | | | | | |
| PBITOE Margin (%) | 14.83 | 9.72 | 8.26 | 18.55 | 16.47 |
| PBTE Margin (%) | 17.34 | 11.74 | 10.84 | 21.16 | 19.26 |
| PBT Margin (%) | 13.08 | 4.50 | 10.84 | 23.87 | 11.73 |
| PAT Margin (%) | 9.67 | 3.34 | 8.02 | 17.51 | 8.71 |